Insider Buying: Retractable Technologies, Inc. (NYSE:RVP) CEO Buys 29,112 Shares of Stock

Retractable Technologies, Inc. (NYSE:RVP) CEO Thomas J. Shaw purchased 29,112 shares of the stock in a transaction dated Wednesday, January 22nd. The stock was purchased at an average price of $0.78 per share, for a total transaction of $22,707.36. Following the completion of the acquisition, the chief executive officer now directly owns 15,006,863 shares in the company, valued at approximately $11,705,353.14. This represents a 0.19 % increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available at the SEC website.

Retractable Technologies Stock Performance

Retractable Technologies stock traded up $0.01 during mid-day trading on Thursday, reaching $0.78. 20,388 shares of the company traded hands, compared to its average volume of 113,821. The firm’s fifty day moving average is $0.67 and its two-hundred day moving average is $0.83. The company has a market capitalization of $23.23 million, a price-to-earnings ratio of -1.44 and a beta of 1.94. Retractable Technologies, Inc. has a fifty-two week low of $0.56 and a fifty-two week high of $1.34. The company has a debt-to-equity ratio of 0.01, a current ratio of 8.57 and a quick ratio of 5.92.

Institutional Trading of Retractable Technologies

A hedge fund recently bought a new stake in Retractable Technologies stock. PFG Investments LLC acquired a new position in Retractable Technologies, Inc. (NYSE:RVP) in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 34,600 shares of the company’s stock, valued at approximately $27,000. PFG Investments LLC owned about 0.12% of Retractable Technologies as of its most recent SEC filing. 7.58% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Separately, StockNews.com initiated coverage on Retractable Technologies in a report on Wednesday. They issued a “hold” rating for the company.

About Retractable Technologies

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.